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Introduction
Bipolar depression is common disorder characterized by
substantial comorbidity, mortality, the highest suicide rate
among psychiatric illnesses and severe social impairment, but is
still often misdiagnosed.
The real prevalence of bipolar depression could be much
higher than is thought, because the problem of misdiagnosis.
A percentage of undiagnosed bipolar patients is especially
high in population of treatment resistant depression. These pa-
tients are most frequently misdiagnosed as having unipolar de-
pression and treated with anitidepressant monotherapy, that re-
sult in worsening of the course of the illness and often lead to
rapid cycling.
Two independent studies 
1, 2 in population of 203 and 250
patients with major depression found 40–49% of bipolar disor-
der. In 1994, the results of survey of National Depressive and
Manic-Depressive Association showed that 73% of 500 bipolar
patients were misdiagnosed as having unipolar major depres-
sion 
3. Unfortunately, 10 years later the same association survey
found that nothing has changed and that 69% of another 600 bi-
polar patients were misdiagnosed in this period of time 
4.
Even when correctly diagnosed, treating bipolar depression
can also be challenging, and after many treatment guidelines it is
often much more difficult to manage bipolar depression than bi-
polar mania. In treatment of bipolar depression particularly deli-
cate, often questionable, demanding “art and science”, are
treatment resistance (require high doses and combinations of
antidepressants)  vs risk of manic switch (sometimes happen
even with the lowest doses of antidepressants in a first few days
of treatment), but also problems of different treatment strategies
in acute and maintenance therapy that often result in the prob-
lem of polypharmacy.
Repetitive transcranial magnetic stimulation in
affective disorders
During the last decade, the use of repetitive transcranial
magnetic stimulation (rTMS) in treatment of pharmaco-
resistant major depressive disorder (MDD) applies increas-
ingly.
rTMS is a neurostimulative technique, in which a mag-
netic stimulation coil is placed over a strictly defined positions
of subjects head. The passage of current through the copper
wire in the coil, leads to induction of magnetic field whose di-
rection is perpendicular to the direction of current flow in the
coil. Such a magnetic field leads to the induction of electric
field in the surface layers of the cerebral cortex, which causes
the activation of interneurons and pyramidal neurons, de-
pending on the intensity of stimulation 
5. The application of a
single magnetic pulse, as described above, leads to  firing of
several descendent potentials along the pyramidal tract, in case
of stimulation of the motor cortex, with the possibility of re-
cording short latency EMG response in the contralateral limb
muscles (latency between 20 and 25 msec) 
6. However, using a
series of magnetic stimuli with precisely defined frequency
and intensity (usually lower than the threshold to cause motor
response) is feasible to induce neuromodulatory effects, inStrana 596 VOJNOSANITETSKI PREGLED Volumen 70, Broj 6
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terms of its effects last beyond the duration of stimulation 
7.
This led to a concept of purposeful modulation of cortical ac-
tivity in order to induce plastic changes 
8. This concept was
confirmed in humans in the example of motor cortex plasticity
induced by motor learning 
9. Low-frequency repetitive TMS
( 1 Hz) causes a consistent and lasting decrease in motor cor-
tical excitability in healthy individuals in contrast to the “fa-
cilitatory” effects induced by high-frequency repetitive TMS
(5–20 Hz) 
10, 11. The knowledge gained in the experiments on
the motor cortex, moreover, as an analogy, used in the expla-
nation of mechanisms of therapeutic effects of rTMS treatment
of depression 
12.
Efficacy of rTMS in major depression has been demon-
strated in many randomized controlled trials 
13–16. However,
only a few rTMS trials in bipolar depression have been pub-
lished in the last 10 years with contradictory findings.
In 2002, the first rTMS study in bipolar depression 
17
showed a significant rTMS efficacy compared to sham, Na-
has 
18 did not have a significant response in the group of 23
bipolar patients, but a recent trial showed also rTMS efficacy
and safety in mixed episodes of bipolar disorder 
19.
rTMS protocols in major depression predominantly
used high frequencies of stimulation ( 5Hz) of the left dor-
solateral prefrontal cortex (DLPFC) and only a few trials
used low frequent ( 1Hz) rTMS of the right DLPFC 
14, 20–22
where antidepressant efficacy was also shown, besides much
better safety profile.
Generally, it is considered that major depression is re-
lated with the functional insufficiency of both left and right
hemispheres, with lower excitability and metabolic hypoac-
tivity in the left prefrontal cortex compared to higher right
frontal cortical excitability. Use of rTMS in treatment of
major depression is based on the opposite effects of  high
frequency ( 5 Hz) and low frequency ( 1 Hz) on cortical
excitability
 23, where low-frequency rTMS leads to reduced
intracortical excitability, regional metabolism and blood
flow 
10, 24 and vice versa for high frequency rTMS 
11, 25.
Iatrogenic induction of hypomanic/manic switch – a
form of bipolar illness?
Antidepressant associated manic switch was reported to
be higher in bipolar type I disorder than unipolar depres-
sion 
26, 27 or bipolar type II 
28, and antidepressant induced
mania during the treatment of unipolar depression is consid-
ered as a sign of latent bipolar disorder 
29.
In unipolar depression, estimates of the rate of antide-
pressant associated mania have been in the range of 0–
25% 
26, 27, 30. Higher rates of antidepressant-associated mania
have been reported in bipolar disorder
 26.
There is still no general consensus should antidepres-
sant-induced mania be coded as a form of bipolar disorder.
The International Classification of Diseases-10 (ICD-10) and
the Diagnostic and Statistical Manual of Mental Disorders-
IV (DSM-IV) still do not code this state as a specific form of
bipolar disorder. However, there is a widespread proposal,
strongly supported by clinical evidences and many expert
opinions, for antidepressant induced mania to be included in
bipolar spectrum, provisionally with the categorization of bi-
polar III affective disorder 
29 and it is also in consideration to
be coded as bipolar affective disorder in DSM-V and ICD-11.
As with pharmacotherapy, iatrogenic induction of
manic or hypomanic switch may occur during almost all
other biological, non-pharmacological treatment for major
depression, such as electroconvulsive therapy 
31, vagus nerve
stimulation 
32, phototherapy 
33 and therapeutic sleep depriva-
tion 
34, 35.
Switch to hypomania/mania during rTMS treatment
of major depression
Fitzgerald and Daskalakis 
36, in an article addressed the
issue of practical guidelines to use rTMS in depression,
based both by review of the literature and experience these
authors have in rTMS in the treatment of major depression
more than 10 years found that the trials specifically of bipo-
lar depression have been too limited at this stage to allow
any conclusions, however rTMS could be reasonable treat-
ment option. They suggest concurrent use of mood stabiliz-
ers during rTMS in these patients, even the risk of manic
switch, in their opinion, is low.
In 2008, Xia et al. 
37 published a review focused on
treatment-emergent mania/hypomania (TEM) associated with
rTMS (37). This review included 53 randomized controlled
trials (RCTs) of rTMS in unipolar and bipolar depression,
published until 2006, where in 10 trials a total of 13 cases of
mania/hypomania were reported (3 cases in RCTs, other 10 in
single or multiple case reports). They found that TEM occur-
rence rate in RCTs, in this sample of both unipolar and bipolar
disorders was 0.84% for active treatment group, and 0.73% for
sham group, which was not statistically different. In total of 65
bipolar patients the switching rate in the active rTMS group
was 3.1% and for unipolar depression was only 0.34%, that all
indicate that rTMS does not have a higher risk of manic switch
than antidepressants pharmacotherapy.
Furthermore, this comprehensive review evaluated phe-
nomenon of hypomanic/manic switch in rTMS trials in rela-
tion with diagnosis (unipolar and bipolar depression), the pa-
rameters of stimulation (laterality, frequency, intensity, du-
ration of stimulus train and intertrain intervals, number of
pulses per session, frequency of sessions), and found that
switch was more often in bipolar depression, in patients who
received two rTMS sessions per day, with no specific rela-
tion with laterality, frequency and duration of stimulus train.
As was mentioned above, in most rTMS studies of ma-
jor depression high frequencies of stimulation were used, as
in reported cases of switch to hypomania/mania but only a
few studies using low frequencies of stimulation in depres-
sion reported switch to hypomania/mania. Ella 
38 reported
two cases of manic switch in patients previously thought to
have unipolar depression during slow (1 Hz) rTMS treatment
of the right DLPFC where number of stimuli per session they
used was 1,200 stimuli/day; in one patient stimulation was
applied during 2 weeks (10 sessions) and in another patient 3
weeks (15 sessions); in both cases the switch occurred few
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In the first placebo-controlled, randomized trial of dif-
ferent frequencies of rTMS in posttraumatic stress disorder
two cases of mania were reported – one in group stimulated
with 1 Hz, another in group stimulated with 10 Hz, in both
cases after only 3 days of stimulation 
39. Hausmann et al. 
40
used bilateral rTMS (20 Hz, 100% of the resting motor
threshold (RMT) over the left DLPFC and 1 Hz, 120% RMT
over the right DLPFC) to enhance antidepressant outcome
but patient switched to mania on day 7 of stimulation; in this
study citalopram was also started on the first day of stimula-
tion, and it’s questionable was switch related to effect of
rTMS, citalopram, or both. In this patient bipolar affective
disorder was already diagnosed, so it’s not clear why she re-
ceived antidepressants without mood stabilizer.
Fitzgerald et al. 
41 2003 in double-blind, parallel design
study reported one switch to mania with stimulation of 1 Hz,
100% RMT, 300 stimuli/session (in group stimulated with 10
Hz was no switch), but that particular patient was the only
one diagnosed as bipolar among the unipolar depressed pa-
tients, and in 2006, the same author published parallel-
crossover study with 1 and 2 Hz, where in 130 stimulated
patients only one manic switch occurred (again, in patient
with bipolar depression).
In addition, Nedjat and Folkerts 
42 also reported tran-
sient hypomanic symptoms in a period of a day during high
frequency rTMS of the left prefrontal cortex (PFC) in 3 of 50
healthy volunteers.
How to manage hypomanic/manic switch if occurs
during rTMS ?
Most of the reported cases of switch to mania occurred
within safety guidelines; the problem is that available guide-
lines focused on prevention of undesired seizures, but still do
not consider prevention and management of manic switch.
This explains why the reported methods of managing
hypomania/mania switches induced by rTMS in all published
case reports were different.
In our case, hypomania has occurred at the end of the
treatment when rTMS was already stopped as scheduled and
we decided to keep antidepressant and carefully monitor pa-
tient during more frequent visits on outpatient clinic. During
follow-up period symptoms of hypomania vanished in 2
weeks 
43. In this case, patients also continued to receive fixed
dose of velafaxine during rTMS treatment associated with
partial sleep deprivation (applied twice during two weeks), so
in this patient hypomanic switch could be induced by syner-
gistic effect of antidepressants treatment with rTMS and par-
tial sleep deprivation as add-on therapy. In the above men-
tioned case reports in one patient after manic switch Ella 
38 re-
ported quick switch beck to depressive mood; valproate and
sertraline were started and patient recovered in 5 weeks.
Sakkas et al. 
44 in their study protocol used more ag-
gressive stimulation with 20 Hz, 110% RMT, 1,600 stimuli/
session, two sessions/day and reported one case of hypoma-
nia and one case of mania. They firstly tried to manage hy-
pomania symptoms in one patient with discontinuation of
antidepressant medication and continued rTMS treatment,
but the patient became more manic; when rTMS was stopped
the patient became depressed again and finally, euthymic
after reintroduction of rTMS, this time stimulation was less
aggressive – only once a day with concomitant use of mood
stabilizers. This report definitely shows that mania-induced
potential of rTMS correlates with the intensity of rTMS, but
our protocol and above mentioned previous case reports 
38, 40
with less intensive stimulation also result in switch to hypo-
mania, that makes understanding of hypomanic/manic switch
during rTMS much more unclear.
In contrary to Sakkas  et al,
44 Cohen  et al,
39 tried to
manage mania during rTMS in posttraumatic stress disorder
patients discontinuing firstly rTMS, then also antidepressant
medication and manic symptoms abated in a 5 days. Haus-
mann et al. 
40 decided to immediately stop both rTMS and
antidepressant medication and started clozapine treatment;
manic symptoms vanished in 5 days, but the patient switched
back to depression and finally recovered after long lack of
response on several antidepressants regimens in the next 3
months; this showed that rTMS treatment had even stronger
antidepressant effect than all used medication. These authors
also hypothesized that rTMS in combination with antidepres-
sant medications might modulate kindling and sensitization
phenomena, which enhance cycle acceleration in bipolar
spectrum patients.
Dolberg et al. 
45 used more intensive stimulation (10
Hz, 1,200 stimuli/day, 4 weeks) and reported two cases of
manic switch that occurred even patients were on valproic
acid during rTMS treatment; these authors decided to in-
crease dose of mood stabilizer in one patient and added halo-
peridol in another patient, but in one of them manic symp-
toms lasted even 2 months.
In another case of manic switch during rTMS Ella et
al. 
38 first had enthusiastic try to stabilize a patient who
switched during stimulation of right DLPFC with 1 Hz
changing frequency of stimulation to 10 Hz at the same
side, based on theories and neuroimaging findings of func-
tional laterality of hemispheres in depression and mania
and the opposite modulator effect of rTMS. This patient did
not recover with this procedure, on the contrary, became
more manic and recovered with valproate and risperidone
treatment, but in the next few years a few case reports and
controlled studies in mania were published, supporting ef-
ficacy of high frequency rTMS of right PFC in ma-
nia 
19, 46, 47.
Use of mood stabilizers during rTMS treatment of bi-
polar depression was proposed to maximize safety, but that
also did not completely stop switches during rTMS 
37, simi-
larly to use of mood stabilizers during antidepressant phar-
macotherapy.
Conclusion
We want to highlight again that in cases of treatment
resistant depression clinicians should always be aware of
possible underlying bipolar disorder.
As another antidepressive biological treatments, rTMS
also has a potential to induce hypomanic/manic switch.Strana 598 VOJNOSANITETSKI PREGLED Volumen 70, Broj 6
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Considering the fact that studies where hypomanic/manic
switches were reported included patients with unipolar and but
also bipolar depression, patients also often received antide-
pressants during rTMS and protocols of stimulation were dif-
ferent, further controlled studies with more specific inclusion
criteria should give precise guidelines.
The idea of changing the frequency of stimulation if
switch occurs looks elegant and already shown promising re-
sults. Further controlled studies of rTMS in mania are needed
to answer if the riddle of manic switch during rTMS treat-
ment of depression could be solved in a way with the same
therapy.
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